Successful T cell engineering with gene scissors
The idea of genetically modifying a patient’s own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as effective as natural T cells and have been only been of limited clinical value. Using the new CRISPR-Cas9 gene editing tool, a team at the Technical University of Munich (TUM) has now engineered T cells that are very similar to physiological immune cells.
There are two forms of T cell therapy: either a recipient receives cells from a donor, or the recipient’s own T cells are removed, genetically reprogrammed in a laboratory and unleashed against an infection or tumor in the body. While the first method has proven to be successful in clinical models, reprogramming T cells is still beset with problems.
The team led by Professor Dirk Busch, Director of the Institute for Medical Microbiology, Immunology and Hygiene at the TUM, has generated modified T cells for the first time that are very similar to their natural counterparts and could solve some of those problems. To do so, they utilized the new CRISPR-Cas9 gene scissors, which can be used to snip out and replace targeted segments of the genome.
Both the conventional methods and the new method target the key homing instrument of T cells, known as the T cell receptor. The receptor, residing on the cell’s surface, recognizes specific antigens associated with pathogens or tumor cells, which the T cell is then able to attack. Each receptor is made up of two molecular chains that are linked together. The genetic information for the chains can be genetically modified to produce new receptors that are able to recognize any desired antigen. In this way, it is possible to reprogram T cells.
Targeted exchange using the CRISPR-Cas9 gene scissors
The problem with conventional methods is that the genetic information for the new receptors is randomly inserted into the genome. This means that T cells are produced with both new and old receptors or with receptors having one old and one new chain. As a result, the cells do not function as effectively as physiological T cells and are also controlled differently. Moreover, there is a danger that the mixed chains could trigger dangerous side effects (Graft-versus-Host Disease, GvHD).
“Using the CRISPR method, we’ve been able to completely replace the natural receptors with new ones, because we’re able to insert them into the very same location in the genome. In addition, we’ve replaced the information for both chains so that there are no longer any mixed receptors,” explains Kilian Schober, who is a lead author of the new study along with his colleague Thomas Müller.
Thomas Müller explains the advantages of the modified T cells: “They’re much more similar to physiological T cells, yet they can be changed flexibly. They’re controlled like physiological cells and have the same structure, but are capable of being genetically modified.“ The scientists have demonstrated in a cell culture model that T cells modified in this way behave nearly exactly like their natural counterparts.
“Another advantage is that the new method allows multiple T cells to be modified simultaneously so that they’re able to recognize different targets and can be used in combination. This is especially interesting for cancer therapy, because tumors are highly heterogeneous,” Dirk Busch adds. In the future, the team plans to investigate the new cells and their properties in preclinical mouse models, an important step in preparing for clinical trials with humans.
Learn more: Successful T cell engineering with gene scissors
The Latest on: CRISPR-Cas9 gene scissors
via Google News
The Latest on: CRISPR-Cas9 gene scissors
- Nobel Prize in Chemistry Goes to Discovery of 'Genetic Scissors' Called CRISPR/Cas9on October 7, 2020 at 1:09 pm
Emmanuelle Charpentier and Jennifer A. Doudna win for technology that gives scientists unprecedented abilities to change the code of life ...
- Creators of Gene 'Scissors' Clinch Nobel as Women Sweep Chemistryon October 7, 2020 at 12:25 pm
Scientists Emmanuelle Charpentier and Jennifer Doudna won the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, the award-giving body said on Wednesday. "Emmanuelle ...
- Crispr–Cas9 gene-editing inventors win chemistry Nobel prizeon October 7, 2020 at 9:18 am
Stafshede from the Nobel committee for chemistry about this year’s prize, which went – perhaps unexpectedly – to Jennifer Doudna from the University of California, Berkeley, US, and Emmanuelle ...
- 2 scientists win Nobel chemistry prize for gene-editing ‘molecular scissors’on October 7, 2020 at 7:01 am
Two scientists won the Nobel Prize in chemistry Wednesday for developing a way of editing genes likened to “molecular scissors” that offer the promise of one day curing inherited diseases. Working on ...
- Two scientists win Nobel chemistry prize for ‘gene scissors’on October 7, 2020 at 5:09 am
Two scientists won the Nobel Prize in chemistry Wednesday for developing a method of genome editing likened to “molecular scissors” that offer the promise of one day curing inherited diseases and ...
- Nobel Peace Prize awarded for “gene scissors”on October 7, 2020 at 4:28 am
Two scientists won the Nobel Prize in chemistry Wednesday for developing a method of genome editing likened to “molecular scissors” that offer the promise of one day curing inherited diseases and even ...
- 2 scientists win Nobel chemistry prize for 'gene scissors'on October 7, 2020 at 3:58 am
Two scientists won the Nobel Prize in chemistry Wednesday for developing a way of editing genes likened to "molecular scissors" that offer the promise of one day curing inherited diseases.
- SMCM professor achieves first gene knockout in a cephalopodon September 30, 2020 at 9:49 am
The team used CRISPR-Cas9 genome editing — a technique used to make a pigmentation gene, one that changes ... To accomplish that, the team developed micro-scissors to clip the egg’s surface ...
- Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugson September 26, 2020 at 4:59 pm
CRISPR-Cas9 gene editing cuts the genome at specific ... “If existing gene editing approaches are ‘scissors’ for the genome, our base editors are ‘pencils,’ erasing and rewriting one ...
- CRISPR Gene Editing Newson September 23, 2020 at 4:59 pm
Sep. 8, 2020 — A new application of the CRISPR/Cas molecular scissors promises progress ... July 16, 2020 — Cas proteins like CRISPR-Cas9 have great potential for gene therapy to treat human ...
via Bing News